We use cookies to give you the best possible experience on our website.

The challenges we face

Companies, especially SMEs, can face significant challenges to introduce their new and innovative products into the NHS. The complexity of public procurement, patient safety and a risk averse culture across multiple organisations can be daunting. The Innovation Nexus aims to provide a single source of resource that can help companies, particularly SMEs, understand the steps that need to be taken to support their business planning and engage with the NHS more easily, thus progressing the adoption of their innovation at pace and with fewer unanticipated obstacles.

a fully funded intensive support programme for life science SMEs working in Greater Manchester

How can the Innovation Nexus help me?

Speak directly to a GM AHSN advisor with NHS expertise

Help with navigating NHS procurement

Information about funding and investment

Help with setting up a trial of your innovation

Information on science parks and office locations

Connect you with relevant organisations

 

Free industry support from NHS experts

If you are a business with an innovative product or service that you believe has the potential to benefit the healthcare market, the Innovation Nexus can give you access a network of specialist advice and support.

Subscribe to our mailing list

* indicates required

Asset Publisher Asset Publisher

Back

Event: Joint EFGCP-MedTech Europe conference, London, June 2015

Event: An Interactive Multi-Stakeholder Conference and Workshop of the Joint EFGCP-MedTech Europe Medical Technology Working Party on Ethics, Quality and Oversight in the Clinical Development of Medical Devices

Date: 15 & 16 June 2015

Location: University College London, London, United Kingdom

Clinical development of medical devices is a continual process spanning the full product lifecycle. Designing, executing, and ensuring oversight of clinical studies across this lifecycle, while meeting the highest standards of quality and ethics, is a special challenge for medical devices as it is for medicines.

The ongoing revision of the EU regulatory framework for medical devices seeks to establish new clinical evidence standards, aligning the rules - where useful and applicable to medical technology - with the new Clinical Trials Regulation for Medicinal Products. Greater harmonisation is also expected in terms of how Member States enforce these rules, such as through inspections and ethics committee overview.

This Joint EFGCP-MedTech Europe conference will explore existing best practices and forthcoming changes in the clinical development of medical devices. Through dialogue between regulators, patients, healthcare professionals, CROs and industry, the event will provide early insight into the future clinical evidence rules for medical devices, while offering regulators insight into the practical challenges facing their stakeholders.

 

More information and registration >>>